Why the study?
Does co-administration of dipyridamole and acetylsalicylic acid alter their pharmacokinetics in healthy volunteers?
Does co-administration of dipyridamole and acetylsalicylic acid alter their pharmacokinetics in healthy volunteers?
Dipyridamole co-administration increases the peak concentration and AUC of acetylsalicylic acid, which may influence its anti-platelet effect.
No takes yet. Share an insight, caveat, or question.
May enhance ASA antiplatelet effect via increased exposure; hypothesis-generating for clinical relevance and dose adjustment in patients.
Nitelius et al. (1985) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: